Daily Status, Sept 2
Daily Status, Sept 2:
The statewide numbers are increasing slowly (less than 1% per day; the growth is solely the result of the outbreaks at some colleges). Outside of college environments, we are doing ok. The best way to describe the situation is: Yesterday, the sky was not falling and today, we are not doing great. But, as locations go, much of Virginia is improving, no overall region is particularly concerning (SW is explained by college outbreaks). We are around the median for all states.
What is most noticeable is the worst part of the state per capita is SW VA. This is a dramatic change from the situation earlier. SW is high mostly from the outbreak at Radford. It is also with noting that Eastern VA's rate of improvement seems to have curtailed, and they actually show their first week over week increase in a month.
The three week growth rates are (in fraction per day)
Central VA: 1.007
Hampton Roads/Eastern VA: 0.976
SW VA: 1.019
NW VA: 1.015
The state as a whole is is increasing at 1.003.
The following charts are for the 5 regions/trends. It is worth noting that for NW and SW VA, the recent uptick are 100% the result of the case surges at Radford & JMU. Note that the total number of new cases SW VA is similar to East/Hampton Roads and Northern VA (though NoVA & Hampton Roads have a significantly more people than SW VA).
% of population infected ****
Large Scale Community Spread:
RADFORD (linked to the university Dashboard)
1) You can repost / share in the entirety by forwarding the link, 2) If you want share partial content, you must receive my permission – I need to make sure you understand what I am saying. If anyone sees this work being used without attribution, please let me know as soon as possible. I am willing to have an informed discussion / debate on my approach, but I want to make sure the proper context is captured.
Why I did this: About the blog
State Actions: Impact on Growth: TBD
Figure Descriptions: TBD
Other Sites: John's Hopkins
Kids can pass covid to parents: Pediatric SARS-CoV-2: Clinical Presentation, Infectivity, and Immune Responses